Is this you?
It's free and only takes 2 minutes.
Not yet reviewed
Endorsements from fellow lawyers are an important consideration for many when selecting the right attorney. Be the first to endorse your colleague!
Are you an attorney? Endorse this lawyer
|GA||Inactive Member in Good Standing||1977||02/04/2017|
|Award name||Grantor||Date granted|
|The Best Lawyers in America||N/A||N/A|
|Best Practices for Food and Drug Law||Essential Elements of FDA Practice and Strategy||2005|
|Fundamentals of Law and Regulation Supplement||Key Provisions of the Food and Drug Modernization Act Relating to Drugs and Biologics||1998|
|Adams, ed.||Fundamentals of Law and Regulation Vol. II: An In-Depth Look at Therapeutic Products||1997|
|Unknown||USPTO and FDA Rulings Limit Uruguay Round Agreements Act Benefits and Protections for Certain Patents on FDA-Regulated Products||1995|
|Unknown||FDA’s Final Regulations on Generic Drug Approval: Marketing Exclusivity||1995|
|Unknown||FDA’s Final Regulations on Generic Drug Approval: Patent Protections, Patent Challenges||1994|
|24 Seton Hall L. Rev., 1399||FDA Regulation of Communications on Pharmaceutical Products||1994|
|47 Food and Drug Law Journal 624||FDA Policy on Industry-Supported Scientific and Educational Activities||1993|
|D. Patak Ed.||Pharmaceutical Advertising: Education versus Promotion||1992|
|7 J. of Pharmaceutical Marketing and Management 53||Pharmaceutical Advertising: Education versus Promotion||N/A|
|Promotion of Pharmaceuticals||Pharmaceutical Advertising: Education versus Promotion||N/A|
|New York University School of Law||N/A||N/A||N/A|
|Food and Drug Law Institute||Patents, Exclusivity, and Generic Drugs||2006|
|Medical Education Congress||Regulatory Liability Based on Support for CME||2005|
|Food and Drug Law Institute||NDAs, ANDAs, Patents, and Exclusivity||2005|
|Drug Information Association||Regulatory Liability Based on Intended Use||2005|
|Pharmaceutical Education Association||Product Life Cycle Management||2004|
|Food and Drug Law Institute||FDA Regulation of Marketing,||2004|
|Drug Information Association||Current Issues in Regulation of Continuing Medical Education||2004|
|American Conference Institute||Disseminating Product Information Prior to Approval||2004|
|Drug Information Association||Current Issues in FDA Regulation of Prescription Drug Promotion||2003|
|Food and Drug Law Institute||FDA’s First Amendment Review||2002|
|Federalist Society||Constitutional Limitations on FDA Regulation of Promotion||2002|
|Drug Information Association||FDA Regulation of Drug Marketing||2002|
|Drug Information Association||Pre-Approval Promotion: How to Do It Legally||2001|
|Drug Information Association||Current FDA Enforcement of Drug Advertising Requirements||2001|
|American Medical Association||Industry-Supported Information on Therapeutic Products||2001|
|Drug Information Association||Constitutional Challenges to FDA Implementation of FDAMA||2000|
|Drug Information Association||Current FDA Enforcement of Drug Advertising Requirements||2000|
|American Conference Institute||Federal Regulation of Drug Information on the Internet||2000|
Claiming your profile is free and easy.
Highlight your practice areas, experience, and contact information.
Showcase your speaking engagements, awards, case histories, and more.